About Gopsi Pharma
Gopsi Pharma is a company based in Pune (India) founded in 1997 by Baldev Prajapati. It operates as a B2B. Gopsi Pharma offers products and services including Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and Meta Cyano Benzyl Bromide. Gopsi Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Pune, India
- Founders Baldev Prajapati
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Gopsi Pharma Private Limited
- Date of Incorporation 27 Jan, 1997
- Jurisdiction Ankleshwar, Gujarat, India
-
Annual Revenue
$893.06 K (USD)8.69as on Mar 31, 2023
-
Net Profit
$152.07 K (USD)164.49as on Mar 31, 2023
-
EBITDA
$221.07 K (USD)113.89as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gopsi Pharma
Gopsi Pharma offers a comprehensive portfolio of products and services, including Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and Meta Cyano Benzyl Bromide.
Chemical used in drug synthesis for pharmaceutical production.
Intermediate compound for various drug manufacturing processes.
Essential chemical in synthesizing active pharmaceutical ingredients.
Compound applied in pharmaceutical derivative formulations.
Used as a building block in pharmaceutical chemical production.
Chemical for creating specialized pharmaceutical compounds.
Intermediate for advanced drug development applications.
Funding Insights of Gopsi Pharma
Detailed funding history for Gopsi Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gopsi Pharma
Investment portfolio details for Gopsi Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gopsi Pharma
Detailed financials for Gopsi Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gopsi Pharma Comparisons
Peer comparison for Gopsi Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gopsi Pharma
Gopsi Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Gopsi Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gopsi Pharma
Complete news archive for Gopsi Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopsi Pharma
Gopsi Pharma was founded in 1997.
Gopsi Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Annual revenue of Gopsi Pharma is $893.06K as on Mar 31, 2023.
Gopsi Pharma Pvt. Ltd. is a manufacturer of pharmaceutical derivatives, specializing in active intermediates like Para Nitro Benzyl Bromide. Based in Bharuch, Gujarat, India, they operate under ISO 9001 certification, focusing on quality control and RD. The company produces a wide range of chemicals for pharmaceutical applications, ensuring compliance with standards and customer requirements through innovative practices and responsible waste management.
Gopsi Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Gopsi Pharma offers Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and 3 more products and services.